Pfizer on Monday reported additional data from their experimental Covid-19 vaccine conducted in Gerrmany on 60 healthy adults that showed it was safe and induced an immune response in patients.
The response echoed results of a similar test conducted in the US.The firms said the data also demonstrated an induction of high level of T-cell responses against the novel coronavirus.Researchers found that patients had a T-cell response, which bodes well for their ability to fend off the virus.
BioNTech shares surged 10% in Germany. Pfizer gained 4% in trading before US markets opened.More than 150 possible vaccines are being developed and tested around the world to try to stop the novel coronavirus pandemic.